Hjem › Dermatomyositis › Pennsylvania
Dermatomyositis kliniske forsøg i Pennsylvania
7 studier for Dermatomyositis søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Philadelphia
- Research Site, Pittsburgh
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
- UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- UPMC Arthritis and Autoimmunity Center, Falk Clinic, Pittsburgh
- UPMC Montefiore Clinical and Translational Research Center (CTRC), Pittsburgh
- UPMC Presbyterian Shadyside Hospital, Pittsburgh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05895786Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
RekruttererFase 1
Alder 18 til 85 · Alle køn · Opdateret 22. jul. 2026 · NCT06371417Intralesional Injection of STS in Treatment of Calcinosis
- UPMC Arthritis and Autoimmunity Center, Pittsburgh
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT06672822Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
- Hospital of the University of Pennsylvania, Philadelphia
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 30. mar. 2026 · NCT02945345Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.